SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001607062-20-000351
Filing Date
2020-12-17
Accepted
2020-12-17 15:43:56
Documents
6
Period of Report
2020-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A ngio121720form8ka.htm 8-K/A 47369
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 6585
3 EXHIBIT 99.2 ex99_2.htm EX-99.2 5850
4 GRAPHIC image_002.gif GRAPHIC 16703
5 GRAPHIC image_004.gif GRAPHIC 8687
6 GRAPHIC image_005.gif GRAPHIC 4696
  Complete submission text file 0001607062-20-000351.txt   102478
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 (416) 364-2551
NUGENEREX IMMUNO-ONCOLOGY, INC. (Filer) CIK: 0001804585 (see all company filings)

IRS No.: 043208418 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K/A | Act: 34 | File No.: 000-56153 | Film No.: 201395968
SIC: 2834 Pharmaceutical Preparations